A circular, abstract pattern with irregular, jagged white lines and shapes on a light gray background, resembling a textured surface or cracked ground.

Publications

From ARC

  1. FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity.

    Nat. Neurosci., November 30, 2008

    Flajolet M., Wang Z., Futter M., Shen W., Nuangchamnong N., Bendor J., et al.

  2. A translational profiling approach for the molecular characterization of CNS cell types.

    Cell, November 13, 2008

    Heiman M., Schaefer A., Gong S., Peterson J.D., Day M., Ramsey K.E., et al.

  3. Application of a translational profiling approach for the comparative analysis of CNS cell types.

    Cell, November 13, 2008

    Doyle J.P., J. Dougherty, Heiman M., Schmidt E.F., Stevens T.R., Ma G., et al.

  4. Understanding synapses: past, present, and future.

    Neuron, November 5, 2008

    T. Südhof and R. Malenka

  5. Autism and brain development.

    Cell, October 30, 2008

    C. Walsh, E. Morrow, and J. Rubenstein

  6. Neuroligins and neurexins link synaptic function to cognitive disease.

    Nature, October 15, 2008

    T. Südhof

  7. Failure of neuronal homeostasis results in common neuropsychiatric phenotypes.

    Nature, October 15, 2008

    Ramocki M.B. and H. Zoghbi

  8. Deletion of MeCP2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress.

    Neuron, September 24, 2008

    Fyffe S.L., Neul J.L., Samaco R.C., Chao H-T., Ben-Shachar S., Moretti P., et al.

  9. Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs.

    Nat. Neurosci., July 31, 2008

    H. Bateup, Svenningsson P., Kuroiwa M., Gong S., Nishi A., N. Heintz, et al.

  10. Distinct face-processing strategies in parents of autistic children.

    Curr. Biol., July 21, 2008

    Spezio M.L., Parlier M., and J. Piven

  11. Identifying autism loci and genes by tracing recent shared ancestry.

    Science, July 10, 2008

    E. Morrow, Yoo S-Y., Flavell S.W., Kim T-K., Lin Y., Hill R.S., et al.

  12. Gene expression patterns in visual cortex during the critical period: Synaptic stabilization and reversal by visual deprivation.

    Proc. Natl. Acad. Sci. U.S.A., July 7, 2008

    Lyckman A.W., Horng S., Leamey C.A., Tropea D., Watakabe A., Van Wart A., et al.

  13. Tuned responses of astrocytes and their influence on hemodynamic signals in the visual cortex.

    Science, June 19, 2008

    Schummers J., Yu H., and M. Sur

  14. MeCP2, a key contributor to neurological disease, activates and represses transcription.

    Science, May 29, 2008

    M. Chahrour, Jung S.Y., Shaw C., Zhou X., Wong S.T.C., Qin J., et al.

  15. Unusually rapid evolution of neuroligin-4 in mice.

    Proc. Natl. Acad. Sci. USA, April 22, 2008

    Bolliger M.F., Pei J., Maxeiner S., Boucard A.A. Grishin N.V., and Südhof T.C.

  16. CASK functions as a Mg2+-independent neurexin kinase.

    Cell, April 17, 2008

    Mukherjee K., Sharma M., Urlaub H., Bourenkov G.P., Jahn R., Südhof T.C., et al.

  17. Role for metabotropic glutamate receptor 5 ( mGluR5 ) in the pathogenesis of fragile X syndrome.

    J. Physiol., March 14, 2008

    Dölan G. and M. Bear

  18. Association between microdeletion and microduplication at 16p11.2 and autism.

    N. Engl. J. Med., February 13, 2008

    L. Weiss, Shen Y., Korn J.M., D. Arking, Miller D.T., Fossdal R., et al.

  19. Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L -DOPA treatment of an animal model of Parkinsonism.

    Proc. Natl. Acad. Sci. USA, February 11, 2008

    Zhang X., Andren P.E., P. Greengard, and Svenningsson P.

  20. Fragile X: translation in action.

    Neuropsychopharmacology, December 31, 2007

    M. Bear, Dölen G., Osterweil E., and Nagarajan N.

  21. Correction of fragile X syndrome in mice.

    Neuron, December 19, 2007

    Dölen G., Osterweil E., Rao B.S.S., Smith G.B., Auerbach D.B., Chattarji S., et al.

  22. Structures of neuroligin-1 and the neuroligin-1/neurexin-1 beta complex reveal specific protein-protein and protein-Ca2+ interactions.

    Neuron, December 19, 2007

    Araç D., Boucard A.A., Ozkan E., Strop P., Newell E., Südhof T.C., et al.

  23. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice.

    Science, October 4, 2007

    Tabuchi K., Blundell J., Etherton M.R., Hammer R.E., Liu X., Powell C.M., et al.

  24. Ten_m3 regulates eye-specific patterning in the mammalian visual pathway and is required for binocular vision.

    PLoS Biol., August 31, 2007

    Leamey C.A., Merlin S., Lattouf P., Sawatari A., Zhou X., Demel N., et al.

  25. A unified genetic theory for sporadic and inherited autism.

    Proc. Natl. Acad. Sci. U S A, July 30, 2007

    Zhao X., Leotta A., Kustanovich V., Lajonchere C., D. Geschwind, K. Law, et al.

  26. Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice.

    Proc. Natl. Acad. Sci. USA, June 24, 2007

    Hayashi M.L., Rao B.S.S., Seo J-S., Choi H-S., Dolan B.M., Choi S-Y., et al.

  27. Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III.

    J. Clin. Invest., May 31, 2007

    Bergmeier W., Goerge T., Wang H-W., Crittenden J.R., Baldwin A.C.W., Cifuni S.M., et al.

  28. Strong association of de novo copy number mutations with autism.

    Science, April 19, 2007

    J. Sebat, Lakshmi B., Malhotra D., Troge J., Lese-Martin C., Walsh T., et al.

  29. Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice.

    Genes Brain Behav., September 30, 2006

    Ehrman L., Williams M.T., Schaefer T.L., Gudelsky G.A., Reed T.M., Fienberg A.A., et al.

  30. Brain evolution and uniqueness in the human genome.

    Cell, September 21, 2006

    Amadio J.P. and C. Walsh

  31. Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens.

    Proc. Natl. Acad. Sci. USA, February 27, 2006

    K. Lee, Y. Kim, Kim A.M., Helmin K., Nairn A.C., and P. Greengard